Mobile apps for real-world evidence in health care

被引:25
作者
Milne-Ives, Madison [1 ]
van Velthoven, Michelle Helena [1 ]
Meinert, Edward [1 ,2 ]
机构
[1] Univ Oxford, Dept Paediat, Oxford, England
[2] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England
关键词
real-world; evidence-based practice; mobile applications; telemedicine; US Food and Drug Administration;
D O I
10.1093/jamia/ocaa036
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The use of real-world evidence for health care research and evaluation is growing. Mobile health apps have often-overlooked potential to contribute valuable real-world data that are not captured by other sources and could provide data that are more cost-effective and generalizable than can randomized controlled trials. However, there are several challenges that must be overcome to realize the potential value of patient-used mobile health app real-world data, including data quality, motivation for long-term use, privacy and security, methods of analysis, and standardization and integration. Addressing these challenges will increase the value of data from mobile health apps to inform real-world evidence and improve patient empowerment, clinical management, disease research, and treatment development.
引用
收藏
页码:976 / 980
页数:5
相关论文
共 42 条
[1]  
[Anonymous], 2019, Policy for Device Software Functions and Mobile Medical Applications
[2]  
[Anonymous], 2013, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.F6009
[3]  
[Anonymous], MOB HLTH APPS INT TO
[4]  
Atreja A, 2017, MOBILIZING MHEALTH I
[5]  
Balto Julia M, 2016, Mult Scler J Exp Transl Clin, V2, p2055217316634754, DOI 10.1177/2055217316634754
[6]   Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence [J].
Bartlett, Victoria L. ;
Dhruva, Sanket S. ;
Shah, Nilay D. ;
Ryan, Patrick ;
Ross, Joseph S. .
JAMA NETWORK OPEN, 2019, 2 (10)
[7]   Differences in mobile health app use: A source of new digital inequalities? [J].
Bol, Nadine ;
Helberger, Natali ;
Weert, Julia C. M. .
INFORMATION SOCIETY, 2018, 34 (03) :183-193
[8]  
Bresnick J., 2016, HLTH IT ANAL 0322
[9]   Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe [J].
Cave, Alison ;
Kurz, Xavier ;
Arlett, Peter .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) :36-39
[10]  
Cella D, 2015, PATIENT-REPORTED OUTCOMES IN PERFORMANCE MEASUREMENT, P1, DOI 10.3768/rtipress.2015.bk.0014.1509